Evidence map›Paper›PMID 30567480›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2019

Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report.

Feiming Ye, Ya Wang, Congqing Wu, Deborah A Howatt, Chia-Hua Wu, Anju Balakrishnan, Adam E Mullick, Mark J Graham, A H Jan Danser, Jian'an Wang and 2 more

Open access · greenAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Angiotensinogen as a Therapeutic Target for Cardiovascular and Metabolic Diseases.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  12. Article
  13. Internalization of Angiotensin-(1-12) in Adult Retinal Pigment Epithelial-19 Cells.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Feiming YeFrom the Department of Cardiology, Cardiovascular Key Laboratory of Zhejiang Province, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China (F.Y., Y.W., J.W.).
Ya WangFrom the Department of Cardiology, Cardiovascular Key Laboratory of Zhejiang Province, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China (F.Y., Y.W., J.W.).
Congqing WuSaha Cardiovascular Research Center (F.Y., Y.W., C.W., D.A.H., A.B., A.D., H.S.L.) University of Kentucky, Lexington.
Deborah A HowattSaha Cardiovascular Research Center (F.Y., Y.W., C.W., D.A.H., A.B., A.D., H.S.L.) University of Kentucky, Lexington.
Chia-Hua WuDepartment of Pharmacology and Nutritional Sciences (C.-H.W., A.D., H.S.L.) University of Kentucky, Lexington.
Anju BalakrishnanSaha Cardiovascular Research Center (F.Y., Y.W., C.W., D.A.H., A.B., A.D., H.S.L.) University of Kentucky, Lexington.
Adam E MullickIonis Pharmaceuticals, Carlsbad, CA (A.E.M., M.J.G.).
Mark J GrahamIonis Pharmaceuticals, Carlsbad, CA (A.E.M., M.J.G.).
A H Jan DanserErasmus MC, Rotterdam, The Netherlands (A.H.J.D.).
Jian'an WangFrom the Department of Cardiology, Cardiovascular Key Laboratory of Zhejiang Province, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China (F.Y., Y.W., J.W.).
Alan DaughertySaha Cardiovascular Research Center (F.Y., Y.W., C.W., D.A.H., A.B., A.D., H.S.L.) University of Kentucky, Lexington.
Hong S LuSaha Cardiovascular Research Center (F.Y., Y.W., C.W., D.A.H., A.B., A.D., H.S.L.) University of Kentucky, Lexington.
University of Kentucky · USIonis Pharmaceuticals (United States) · USSecond Affiliated Hospital of Zhejiang University · CN

Funding

Atherosclerosis Mechanisms: Angiotensin II production and actionR01HL139748 · NHLBI · UNIVERSITY OF KENTUCKY · PI DAUGHERTY, ALAN, LU, HONG SHEN · 2018 to 2021
$2.0M
NHLBI NIH HHS R01 HL139748
6 · The paper itself

Abstract

Objective- AGT (Angiotensinogen) is the unique precursor of the renin-angiotensin system that is sequentially cleaved by renin and ACE (angiotensin-converting enzyme) to produce Ang II (angiotensin II). In this study, we determined how these renin-angiotensin components interact with megalin in kidney to promote atherosclerosis. Approach and Results- AGT, renin, ACE, and megalin were present in the renal proximal convoluted tubules of wild-type mice. Hepatocyte-specific AGT deficiency abolished AGT protein accumulation in proximal tubules and diminished Ang II concentrations in kidney, while renin was increased. Megalin was most abundant in kidney and exclusively present on the apical side of proximal tubules. Inhibition of megalin by antisense oligonucleotides (ASOs) led to ablation of AGT and renin proteins in proximal tubules, while leading to striking increases of urine AGT and renin concentrations, and 70% reduction of renal Ang II concentrations. However, plasma Ang II concentrations were unaffected. To determine whether AGT and megalin interaction contributes to atherosclerosis, we used both male and female low-density lipoprotein receptor

Indexed as

Angiotensin IIAngiotensinogenAnimalsAtherosclerosisFemaleHypercholesterolemiaLow Density Lipoprotein Receptor-Related Protein-2MaleMiceMice, Inbred C57BLOligonucleotides, AntisenseRenin-Angiotensin SystemAngiotensin IIAngiotensinogenLow Density Lipoprotein Receptor-Related Protein-2Lrp2 protein, mouseOligonucleotides, Antisenseangiotensinogenangiotensinsatherosclerosismicerenin

Identifiers

PMID30567480
PMCPMC6344256
OpenAlexW2906488017

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.